EUVIMED · CrossrefZeitschrift
Pediatric Pulmonology
ISSN 1099-0496 · Wiley
Neueste Artikel
Pre‐ and Postnatal Predictors of Chronic Lung Disease in Congenital Diaphragmatic Hernia
International Collaboration in Primary Ciliary Dyskinesia
Subtle Alterations of Tidal Breathing Variables in Healthy Late Preterm Neonates at Term‐Equivalent Age
When Two Wood Units Matter: From Measurement Bias to Clinical Reclassification in Pediatric Pulmonary Hypertension
United Kingdom Professional Consensus on Candidate Items and Domains for Age Specific Paediatric Bronchiectasis Quality of Life Questionnaires: An e‐Delphi Study
The Persistent Infiltrate: A Diagnostic Challenge
The Association Between Meconium Ileus and Nutritional and Pulmonary Outcomes in Children With Cystic Fibrosis
Beyond the Lungs: Social and Parental Factors Associated With Exercise Capacity and Respiratory Muscle Strength in Children With Cystic Fibrosis
Cystic Fibrosis in Egypt
Cytokine Profile Changes in Infants With Respiratory Syncytial Virus Bronchiolitis With Nirsevimab
Decline of RSV Bronchiolitis as the Leading Cause of Hospital Admissions in the Nirsevimab Era
A Delphi‐Based Item Set for Pre‐Test Asthma Probability Assessment in Children Undergoing Methacholine Challenge Test
Understanding Quality of Life in Pediatric Cystic Fibrosis: Insights From a Multicenter Cohort Study Across Colombia
Health‐Related Quality of Life and Preference‐Based Utility Index in People With Cystic Fibrosis Receiving Elexacaftor/Tezacaftor/Ivacaftor: A National Registry Study
The Use of Overnight Oximetry and Polysomnography in Late Preterm to Term Newborns Requiring Home Oxygen at Discharge
Factors Guiding Gastrostomy Tube Decision‐Making for Caregivers of Children With Cystic Fibrosis: A Scoping Review
Allergic Bronchopulmonary Aspergillosis Presenting as a Chest Mass in a Pediatric Patient: A Case Report
Double Hydatid Cysts Presenting With Characteristic Findings in the Right Hemithorax
Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis and N1303K Variant: Experience in a Pediatric Cohort
Functional Exercise Capacity and Exploratory ICF‐Aligned Interpretation of the Incremental Shuttle Walk Test in Children With Asthma
Comparing Multiple Breath Washout Parameters in a Matched Cohort of Children With Cystic Fibrosis and Primary Ciliary Dyskinesia
Algorithm‐Based Decision‐Making on the Need for Antimicrobial Treatment in Hospitalized Children With Respiratory Tract Infections: A Retrospective Study
Population Pharmacokinetic and Exposure‐Response Analysis of Vancomycin Nephrotoxicity in Cystic Fibrosis Patients
Impact of Elexacaftor/Tezacaftor/Ivacaftor on Systemic Antibiotic Utilization in Pediatric Patients With Cystic Fibrosis
Unmasking a Deeper Cause of Persistent Lung Disease: More Than Just Pneumonia
Comment on “Early Life Food Desert Status Is Associated With Alpha and Gamma‐Tocopherol Levels and Infant Lung Function”
National Case‐Series of Pediatric Mycoplasma pneumoniae Pleural Empyema
Comment on “Early Life Food Desert Status Is Associated With Alpha and Gamma Tocopherol Levels and Infant Lung Function”
Timing of Magnesium Sulfate Cessation and Apnea of Prematurity in Late‐Preterm Twin Infants
Biologic Therapies and Biomarkers in Severe Childhood Asthma: A Systematic Review of Omalizumab and Mepolizumab
Jahrgänge
2026 · 3322025 · 6922024 · 5752023 · 5432022 · 4712021 · 5902020 · 5632019 · 3302018 · 2912017 · 2222016 · 1242015 · 1442014 · 1422013 · 1862012 · 1862011 · 1882010 · 1822009 · 1982008 · 1942007 · 2072006 · 2012005 · 1832004 · 2722003 · 2052002 · 1952001 · 2802000 · 2461999 · 4091998 · 2771997 · 3961996 · 2301995 · 2341994 · 1761993 · 1691992 · 2001991 · 1641990 · 1411989 · 1451988 · 1151987 · 102
EUVIMED